A group of Russian feed additive manufacturers have agreed to deepen cooperation with the Belarussian National Biotechnological Corporation (BNBC). During the 2nd Biotechnological Forum of the Union State of Russia and Belarus held in Minsk in early July, Belgorod's Premix Plant No. 1 and Tyumen's AminoSib said they would “exchange experiences and share developments” with BNBC.
As an example of the cooperation, BNBC CEO Daniil Uritsky revealed that market players had made a fundamental decision that no new lysine plants would need to be built in Russia. “We all remember that we are not competitors. We complement each other’s [production],” he said.
In turn, BNBC would aim to ramp up threonine and tryptophan production to help meet domestic Russian demand. BNBC said that its production capacity in 2023 was 6,000 tonnes/year for threonine and 1,300 tonnes/year for tryptophan.
Lev Dengov, a member of the BNBC board, also disclosed that a goal of the collaboration would involve establishing a single biotechnological cluster, comprised of Russian feed additive manufacturers and BNBC. Dengov did not provide additional details.
Sergey Mikhnyuk, executive director of the Russian National Feed Union, commented that the parties are looking into what capacities could be included in the cluster. He added that not only existing operations are considered, but also those slated to become operational in the next three to five years.
BNBC reaffirmed its plans to reach out to new markets. In 2023, the company got a green light to export its products to Brazil, and new markets are expected to follow shortly.
“We will go to the Middle East, Southeast Asia and South America – to the niches where we still can compete with our Chinese colleagues,” Uritsky said.
According to Mikhnyuk, BNBC has just reached its designed production performance and exports to the new markets will require boosting output.
